Advertisement
For UK healthcare professionals only
March 2016 Br J Cardiol 2016;23:16–20 doi:10.5837/bjc.2016.008
Theresia A M Backhuijs, Hilde Joosten, Pieter Zanen, Hendrik M Nathoe, Mathias Meine, Pieter A Doevendans, Frank J G Backx, Rienk Rienks
Introduction An implantable cardioverter defibrillator (ICD) is used for primary and secondary prophylaxis in the treatment of life-threatening arrhythmia. Guidelines for ICD patients, originally published in 2005, advise against any competitive sports more vigorous than ‘Class IA’ activities such as bowling or golf.1 American College of Cardiology (ACC)/American Heart Association (AHA)/European Society of Cardiology (ESC) embraced this advice stating “for legal and ethical reasons athletes receiving cardiovascular drugs and devices such as pacemakers and ICDs are generally not allowed to participate in high-grade competition.”2 For
For healthcare professionals only
You need to be a member to print this page.
Find out more about our membership benefits
You need to be a member to download PDF's.
Find out more about our membership benefits